Mantell Associates

Eli Lilly and Company has dropped (PDF) the lead candidate from its $2.4 billion takeover of Dice Therapeutics, shifting the focus of its oral IL-17 psoriasis program to a follow-up molecule. Lilly kicked DC-806 to the curb as part of a third-quarter cull that also affected the PD-1 autoimmune prospect peresolimab. Read more below: https://lnkd.in/eCnAiRKX #therapeutics #psoriasis #clinicaltrials

New opportunity! Junior Mechanical Engineer - MedTech - USA. Mantell Associates has formed a partnership with an innovative Industrial Machinery organisation who is seeking a Junior Mechanical Engineer. Apply for this role online - https://lnkd.in/eGpfV2SW - or contact Georgia Read at +44 (0)20 3854 7700. #engineerjobs #engineeringjobs #medtech

We have reached 100,000 followers on LinkedIn! Reaching our yearly goal 2 months early, this is a huge achievement for Mantell Associates - our LinkedIn network having grown from almost nothing to 100k in the past 5 years. Thank you to everyone who has followed the MA journey since 2019. We look forward to continuing to connect with you all, providing industry insights and news as well as incredible opportunities within the Pharmaceutical and Life Science space. #followers #milestone #recruitment

McGuff Pharmaceuticals, Inc. has received FDA approval of its cGMP facility in Santa Ana, CA. This facility is a state-of-the-art, 86,000-sq.-ft. sterile fill-and-finish pharmaceutical manufacturing plant. Read more below: https://lnkd.in/eCfNkkTj #fillandfinish #cdmo #pharmamanufacturing

Baxter International Inc. plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to distributors. Read more below: https://lnkd.in/eErRpm5y #fluids #pharmanews #pharmamanufacturing

Evotec has expanded its strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline. Key achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology, triggering a program-based payment of $50 million to Evotec. Read more below: https://lnkd.in/e-V77jGb #oncology #proteomics #pharmanews

A fantastic recommentation for Tom Bryan, our Contract Divisional Manager. "If you are looking for a recruitment firm that truly goes the extra mile, Mantell Associates is the one you need on your side. Their professionalism, industry expertise, and tailored approach set them apart from other firms. They genuinely care about finding the right fit for both candidates and companies, making the entire process smooth and successful." Contact Tom Bryan on +44 (0)20 3854 7700. #testimonial #pharmarecruitment #londonrecruitment

BD, a global medical technology company, has entered a strategic collaboration with Ypsomed AG, a developer of injection systems, to advance self-injection solutions for high-viscosity biologic drugs. Read more below: https://lnkd.in/eAUs9a6a #drugdelivery #medicaldevices #medtech

The FDA has endorsed Pfizer’s RSV vaccine Abrysvo for adults ages 18 to 59 who are at an increased risk of developing lower respiratory tract disease (LRTD). The approval makes the shot the first of its kind for adults who are younger than 50 years old. Read more below: https://lnkd.in/eKTQX48f #vaccines #pahrmanews #virus

Matica Biotechnology, Inc., a CDMO specializing in viral vector development and manufacturing, has signed a Letter of Intent with KaliVir Immunotherapeutics, a US based clinical-stage biotechnology company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapies. Read more below: https://lnkd.in/e2KNyRZv #manufacturing #virus #celltherapy